Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05904301

Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases

Armenian Nationwide Registry of Systemic Autoimmune and Autoinflammatory Diseases

Status
Recruiting
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Santé Arménie French-Armenian Research Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Longitudinal prospective multicenter Armenian registry of systemic autoimmune, autoinflammatory diseases with constitution of bio-banking.

Detailed description

Autoimmune and auto inflammatory diseases are a growing group of disorders caused by a dysregulation of the innate immune system leading to episodes of systemic inflammation. They represent a group of diseases characterized by excessive autoimmune or inflammatory reaction leading to various organ damage and drop in patient's quality of life, usually underlined by particular genetic factors and environmental triggers. The progress of these diseases is often evaluated in the form of activity scores. A number of scores are available to predict the evolution of autoimmune autoinflammatory diseases. For a long time, these pathologies have remained slightly explored because of their complex physiopathology and the absence of specific therapies. In the last few years, significant progress has been made in terms of both pathophysiology and treatment. Treatment with biological targeted therapies transformed the prognosis and survival of the patients, improved their quality of life and underlined the necessity of a global management of these patients. In Armenia, the epidemiological elements of these pathologies are not known, nor are the circumstances of their discovery. The initial biological manifestations and the management of these patients are variable from one center to another, whether in terms of supportive or specific therapeutic elements.

Conditions

Interventions

TypeNameDescription
OTHERUsual medical management of patients, additional blood and stool samples for biobankingFor all systemic diseases the following data will be collected: Clinical examination, Laboratory data, Current medications, Constitution of biobanking. For each disease: Pathology specific Activity score, Global subjective disease activity by patient and by physician.

Timeline

Start date
2023-06-21
Primary completion
2028-06-30
Completion
2028-06-30
First posted
2023-06-15
Last updated
2025-04-08

Locations

6 sites across 1 country: Armenia

Source: ClinicalTrials.gov record NCT05904301. Inclusion in this directory is not an endorsement.